What is BioLaurus?
BioLaurus is a molecular imaging preclinical drug/device contract research laboratory. We're working with leading biotech and pharmaceutical companies to accelerate drug/device development, and deliver the most translationally relevant research results. From consulting on study design through project execution, BioLaurus is focused on solutions that accelerate your research projects.
 
 
 

Preclin Platform®
BioLaurus's core competency is in its integrated multimodality imaging platform.
Imaging modalities include:
  • SPECT
  • PET
  • CT
  • Micro CT (ex vivo, specimen)
  • MRI
  • Micro Ultrasound
  • Optical
  • Intravital Microscopy
  • Microdialysis
read more
 
 
 

BioLaurus Services

BioLaurus combines an array of cutting-edge technologies and disease models, enabling the company to deliver a remarkable portfolio of first-in-class innovative services to its customers.

BioLaurus's service areas include:

  • PK/PD
  • ADME
  • MOA
  • Efficacy
  • Imaging Toxicology/Safety

Each of these service offerings is available as a conventional preclinical study or as a longitudinal study.

Longitudinal Studies


BioLaurus's technology platform and molecular imaging lab capabilities enable it to be the first CRO capable of performing multi modality longitudinal studies across the preclinical spectrum. Learn More

Imaging Toxicology


BioLaurus is the CRO leader in the emerging field of Imaging Toxicology. Learn More
 
 
 
Ultrasound cardiac strain analysis
Ultrasound cardiac strain analysis – example of drug induced rat heart dysfunction indicated by asymmetry of myocardial motility during heart beat